New drug ZGGS15 tested in patients with advanced cancers
Disease control
Completed
This early-stage study tested a new drug called ZGGS15 in 22 adults with advanced solid tumors that no longer respond to standard treatments. The main goals were to find a safe dose and check for side effects. Researchers also looked for signs that the drug might shrink tumors.
Phase: PHASE1 • Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd • Aim: Disease control
Last updated May 04, 2026 16:24 UTC